Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hologic (GB:0J5Q)
LSE:0J5Q
Hologic (0J5Q) Share Price & Analysis
1 Followers
0J5Q Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$64.69 - $86.55
Previous Close$76.41
Volume18.44K
Average Volume (3M)1.82K
Market Cap
$17.89B
Enterprise Value$18.54B
Total Cash (Recent Filing)$1.93B
Total Debt (Recent Filing)$2.58B
Price to Earnings (P/E)36.3
Beta0.89
Next Earnings
May 02, 2024EPS Estimate
$0.98Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.10
Shares Outstanding234,731,521
10 Day Avg. Volume460
30 Day Avg. Volume1,818
Standard Deviation0.12
R-Squared0.16
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)34.34
Price to Sales (P/S)4.67
Price to Cash Flow (P/CF)20.10
P/FCF Ratio19.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.65
Enterprise Value/Gross Profit6.51
Enterprise Value/Ebitda26.15
Forecast
1Y Price Target
$85.50Price Target Upside11.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Hologic News
Bulls Say, Bears Say
Bulls Say
Financial OutlookManagement raised their FY24 revenue and EPS guidance, indicating confidence in the company's future financial performance.
Operational EfficiencyGross margin exceeded estimates which signals efficient cost management and profitability.
Product LaunchThe FDA approval of their Genius Digital diagnostic system should add another layer of growth when launched later this year.
Bears Say
Competitive PositionHOLX's 3-year revenue and EPS compound annual growth rate remain below peers, with limited upside potential from higher-growth assets or opportunities for margin expansion.
Financial PerformanceDiagnostics revenue of approximately $448M was down 19.9% reported year over year, driven primarily by lower COVID testing revenue.
Regulatory UpdateIf the USPSTF update favors primary hrHPV testing, it is likely to pressure HOLX shares as HOLX does not have a primary hrHPV test in the US.
---
Options Prices
Currently, No data available
---
Ownership Overview
14.45% Insiders
32.65% Mutual Funds
27.02% Other Institutional Investors
25.88% Public Companies and
Individual Investors
0J5Q FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest share price was $64.69 and its highest was $86.55 in the past 12 months.
What is Hologic’s market cap?
Currently, no data Available
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is May 02, 2024 which is in 8 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on Feb 01, 2024. The company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.03.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is $0.98.
How many shares outstanding does Hologic have?
Hologic has 234,731,520 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $0.98 in its last earnings report, beating expectations of $0.95. Following the earnings report the stock price went down -3.443%.
Which hedge fund is a major shareholder of Hologic?
Among the largest hedge funds holding Hologic’s share is Bridgewater Associates, LP. It holds Hologic’s shares valued at 30M.
---
Hologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$85.50 (11.90% Upside)
$85.50 (11.90% Upside)
Blogger Sentiment
Bullish
GB:0J5Q Sentiment 75%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $690.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.32%
12-Months-Change
Fundamentals
Return on Equity
10.57%
Trailing 12-Months
Asset Growth
-8.83%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.
---
0J5Q Company Deck
---
0J5Q Earnings Call
Q1 2024
0:00 / 0:00
---
0J5Q Revenue Breakdown
46.65% Diagnostics
35.55% Breast Health
14.99% GYN Surgical
2.81% Skeletal Health
---
0J5Q Stock 12 Months Forecast
Average Price Target
$85.50
▲(11.90% Upside)
Technical Analysis
Best Analysts Covering 0J5Q
1 Year
1 Year Success Rate
10/14 ratings generated profit
1 Year Average Return
+23.15%
reiterated a buy rating 15 days ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +23.15% per trade.
---